New Year Bumper Sale @ Rs. 1 X
Ifoneon is an allopathic medicine The correct dosage of Ifoneon depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Ifoneon is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Ifoneon is used -
Severe
Moderate
Mild
Common
Is the use of Ifoneon safe for pregnant women?
Is the use of Ifoneon safe during breastfeeding?
What is the effect of Ifoneon on the Kidneys?
What is the effect of Ifoneon on the Liver?
What is the effect of Ifoneon on the Heart?
Ifoneon should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ifoneon unless your doctor advises you to do so -
Is this Ifoneon habit forming or addictive?
Interaction between Food and Ifoneon
Interaction between Alcohol and Ifoneon
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 670-671
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 860
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ifex (ifosfamide)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Holoxan (ifosfamide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methotrexate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 862-863
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 832-834